tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

SLN Stock Latest News

Silence Therapeutics weakness after AHA updates ‘overdone,’ says BMO Capital
The FlySilence Therapeutics weakness after AHA updates ‘overdone,’ says BMO Capital
7d ago
SLN
SILENCE THERAPEUTICS PLC SPONSORED ADR trading resumes
PremiumThe Fly
SILENCE THERAPEUTICS PLC SPONSORED ADR trading resumes
7d ago
SLN
SILENCE THERAPEUTICS PLC SPONSORED ADR trading halted, volatility trading pause
PremiumThe Fly
SILENCE THERAPEUTICS PLC SPONSORED ADR trading halted, volatility trading pause
7d ago
SLN
Silence Therapeutics Showcases Promising Phase 2 Results
PremiumCompany Announcements
Silence Therapeutics Showcases Promising Phase 2 Results
8d ago
6K
SLN
Silence Therapeutics presents late-breaking Phase 2 zerlasiran data at AHA
PremiumThe Fly
Silence Therapeutics presents late-breaking Phase 2 zerlasiran data at AHA
8d ago
SLN
Silence Therapeutics: Rising Assets Amid Growing Losses
PremiumCompany AnnouncementsSilence Therapeutics: Rising Assets Amid Growing Losses
12d ago
6K
SLN
Silence Therapeutics Plc (SLN) Q3 Earnings Cheat Sheet
Premium
Pre-Earnings
Silence Therapeutics Plc (SLN) Q3 Earnings Cheat Sheet
17d ago
SLN
Silence Therapeutics files automatic ordinary shares offering
Premium
The Fly
Silence Therapeutics files automatic ordinary shares offering
1M ago
SLN
AstraZeneca deal has positive read for Silence Therapeutics, says Morgan Stanley
PremiumThe Fly
AstraZeneca deal has positive read for Silence Therapeutics, says Morgan Stanley
2M ago
AZN
SLN
AstraZeneca, CSPC deal shows Lp(a) space remains hot, says BMO Capital
PremiumThe Fly
AstraZeneca, CSPC deal shows Lp(a) space remains hot, says BMO Capital
2M ago
AZN
BMY
Silence Therapeutics initiated with a Buy at Jefferies
PremiumThe Fly
Silence Therapeutics initiated with a Buy at Jefferies
3M ago
SLN
Silence Therapeutics Reports Increased Losses
PremiumCompany Announcements
Silence Therapeutics Reports Increased Losses
3M ago
6K
SLN
Seven new option listings and one option delisting on July 10th
PremiumThe FlySeven new option listings and one option delisting on July 10th
5M ago
SLN
AFCG
Silence Therapeutics price target raised to $55 from $42 at Chardan
Premium
The Fly
Silence Therapeutics price target raised to $55 from $42 at Chardan
5M ago
SLN
Silence Therapeutics price target raised to $49 from $45 at Morgan Stanley
Premium
The Fly
Silence Therapeutics price target raised to $49 from $45 at Morgan Stanley
5M ago
SLN
Silence announces results from repeat dose study of divesiran for PV
PremiumThe Fly
Silence announces results from repeat dose study of divesiran for PV
5M ago
SLN
Silence Therapeutics’ Divesiran Shows Promise in PV Study
PremiumCompany Announcements
Silence Therapeutics’ Divesiran Shows Promise in PV Study
5M ago
6K
SLN
Silence Therapeutics Secures $2M Milestone Payment
PremiumCompany Announcements
Silence Therapeutics Secures $2M Milestone Payment
5M ago
6K
SLN
Silence Therapeutics achieves $2M research milestone payment from Hansoh Pharma
PremiumThe Fly
Silence Therapeutics achieves $2M research milestone payment from Hansoh Pharma
5M ago
SLN
Silence Therapeutics’ Zerlasiran Shows Promising Results
PremiumCompany AnnouncementsSilence Therapeutics’ Zerlasiran Shows Promising Results
5M ago
6K
SLN
Silence Therapeutics announces 48-week data from Phase 2 study of zerlasiran
Premium
The Fly
Silence Therapeutics announces 48-week data from Phase 2 study of zerlasiran
5M ago
SLN
Silence Therapeutics Shareholders Approve Resolutions
Premium
Company Announcements
Silence Therapeutics Shareholders Approve Resolutions
6M ago
6K
SLN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >